| 已發行股份 | 29,119,476 shares |
| 內部人士股份 | 28,733,709 shares |
| 內部持股 | 98.68 % |
| 所有內部人士 | 22 |
內部人士情緒分數
「內部人士情緒分數」用於查找被公司內部人士購入的公司。
它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。
更新頻率：每日
高管情緒分數
「高管情緒分數」用於查找被公司管理層購入的公司。
根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。
如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。
更新頻率：每日
關鍵內部人士指標
此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。
舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。
內幕交易圖表
以下圖表顯示了Hepion Pharmaceuticals, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。
內部人員名單及盈利指標
這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。
See our leaderboard of most profitable insider traders.
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
| Thomas Phd Adams | 91,050 | ||
| Sireesh Appajosyula Director - [D] | 1,250,000 | 1,250,000 | |
| John P Brancaccio Director - [D] | 7,008 | 200 | |
| Block Timothy M. | 91,276 | ||
|
Gabriel Cerrone
10% Owner -
|
10,289,012 | 10,289,012 | |
| John T Cavan Chief Financial Officer - [O] | 14,800 | 423 | |
| Bernard Denoyer Chief Financial Officer - [O] | 1,030 | 1,030 |
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
| Robert T Foster CEO and Director, Director - [D] [O] | 50,470 | 1,009 | |
|
Donald E Garlikov
10% Owner -
|
6,640,000 | 6,640,000 | |
| Tamar D Howson | 80,000 | ||
| William Karl Hornung | 165,000 | ||
| Gary S Jacob Director - [D] | 12,059 | 345 | |
| Arnold Lippa | 91,110 | ||
| Chase LoPriore Director - [D] | 1,250,000 | 1,250,000 |
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|---|---|---|
|
Vincent S LoPriore
Executive Chairman, Director, 10% Owner -
[D]
[O]
|
6,250,000 | 6,250,000 | |
| Christopher McGuigan | 415,234 | ||
| Purcell Michael J. Director - [D] | 1,250,000 | 1,250,000 | |
| James Sapirstein Chief Executive Officer, Director - [D] [O] | 492,819 | 492,819 | |
|
Synergy Pharmaceuticals, Inc.
10% Owner -
|
0 | 0 | |
| Stetz Gary S. Interim CEO, Director - [D] [O] | 1,250,000 | 1,250,000 | |
| John Z Sullivan-Bolyai Chief Medical Officer - [O] | 58,681 | 58,681 | |
| Peter Wijngaard Director - [D] | 9,501 | 190 |
Report errors via our new Insider Auditing Tool
追蹤內部人士買入記錄 - 短期收益分析
在這一部分，我們分析了在 HEPA / Hepion Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
追蹤內部人士賣出記錄 - 短期虧損分析
在這一部分，我們分析了在 HEPA / Hepion Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
| 交易日期 | 內部人士 | 報告 股數 |
報告 價格 |
經調整 股數 |
經調整 價格 |
成本基礎 | 達到最低利潤的 天數 |
達到最低利潤時的 價格 |
避免的 最高損失金額($) |
避免的 最高損失率($) |
|---|---|---|---|---|---|---|---|
| 當前未知該內部人士進行過任何未預先計劃的公開市場交易。 |
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
交易歷史
點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。
| 呈報 日期 |
交易 日期 |
表格 | 內部人士 | 證券代碼 | 證券種類 | 代碼 | 直接 | 行使 價格 |
單位 價格 |
股數 變化 |
價值 變化 (1K) |
剩餘 期權 |
剩餘 股份 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 3 | LoPriore Chase | HEPA | Common Stock, par value $0.0001 per share | D | 1,250,000 | ||||||||
| 2026-04-27 | 2026-04-21 | 4 | Purcell Michael J. | HEPA | Common Stock, par value $0.0001 per share | D | 0.0400 | 1,250,000 | 50 | 1,250,000 | ||||
| 2026-04-27 | 2026-04-21 | 4 | Stetz Gary S. | HEPA | Common Stock, par value $0.0001 per share | I | 0.0400 | 1,250,000 | 50 | 1,250,000 | ||||
| 2026-04-27 | 2026-04-21 | 4 | Appajosyula Sireesh | HEPA | Common Stock, par value $0.0001 per share | D | 0.0400 | 1,250,000 | 50 | 1,250,000 | ||||
| 2026-04-27 | 2026-04-21 | 4 | LoPriore Vincent S By Invictus Capital Advisors Pension Plan | HEPA | Common Stock, par value $0.0001 per share | I | 0.0400 | 1,250,000 | 50 | 6,250,000 | ||||
| 2026-04-27 | 2026-04-21 | 4 | LoPriore Vincent S By Gravitas Capital LP | HEPA | Common Stock, par value $0.0001 per share | I | 0.0400 | 5,000,000 | 200 | 5,000,000 | ||||
| 2023-11-28 | 2023-11-27 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 3.0500 | 2,500 | 8 | 9,501 | ||||
| 2023-11-28 | 2023-11-24 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 3.0900 | 2,500 | 8 | 7,001 | ||||
| 2023-09-20 | 2023-09-19 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 5.6400 | 1,000 | 6 | 4,501 | ||||
| 2023-09-20 | 2023-09-15 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 5.3700 | 861 | 5 | 3,501 | ||||
| 2023-09-20 | 2023-09-15 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 5.4500 | 139 | 1 | 2,640 | ||||
| 2023-09-20 | 2023-09-15 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 5.8200 | 1,000 | 6 | 2,501 | ||||
| 2023-09-19 | 2023-09-18 | 4 | Foster Robert T | HEPA | Common Stock | D | 5.6000 | 1,600 | 9 | 50,470 | ||||
| 2023-09-18 | 2023-09-15 | 4 | Foster Robert T | HEPA | Common Stock | D | 5.4000 | 1,600 | 9 | 48,870 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Lippa Arnold | HEPA | Stock Options | D | 1.70 | 200,000 | 291,110 | |||||
| 2021-05-20 | 2021-05-18 | 4 | Wijngaard Peter | HEPA | Stock Options | D | 1.70 | 200,000 | 260,000 | |||||
| 2021-05-20 | 2021-05-18 | 4 | Cavan John T | HEPA | Stock Options | D | 1.70 | 1,200,000 | 1,581,060 | |||||
| 2021-05-20 | 2021-05-18 | 4 | Foster Robert T | HEPA | Stock Options | D | 1.70 | 1,900,000 | 2,501,879 | |||||
| 2021-05-20 | 2021-05-18 | 4 | JACOB GARY S | HEPA | Stock Options | D | 1.70 | 250,000 | 342,785 | |||||
| 2021-05-20 | 2021-05-18 | 4 | BRANCACCIO JOHN P | HEPA | Stock Options | D | 1.70 | 200,000 | 291,332 | |||||
| 2021-05-20 | 2021-05-18 | 4 | ADAMS THOMAS PHD | HEPA | Stock Options | D | 1.70 | 200,000 | 291,050 | |||||
| 2021-05-20 | 2021-05-18 | 4 | Block Timothy M. | HEPA | Stock Options | D | 1.70 | 200,000 | 291,276 | |||||
| 2021-02-18 | 2021-02-16 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 2.2000 | 10,000 | 22 | 30,000 | ||||
| 2021-02-18 | 2021-02-18 | 4 | Foster Robert T | HEPA | Common Stock | D | 2.0000 | 20,000 | 40 | 45,259 | ||||
| 2021-02-18 | 2021-02-18 | 4 | Cavan John T | HEPA | Common Stock | D | 2.0000 | 10,000 | 20 | 14,800 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Wijngaard Peter | HEPA | Common Stock | D | 1.9100 | 20,000 | 38 | 20,000 | ||||
| 2020-12-08 | 2020-12-08 | 4 | Foster Robert T | HEPA | Common Stock | D | 1.5767 | 25,000 | 39 | 25,259 | ||||
| 2020-12-02 | 2020-12-02 | 4 | BRANCACCIO JOHN P | HEPA | Common Stock | D | 1.5300 | 7,000 | 11 | 7,008 | ||||
| 2020-12-01 | 2020-12-01 | 4 | JACOB GARY S | HEPA | Common Stock | D | 1.6600 | 12,000 | 20 | 12,059 | ||||
| 2020-11-30 | 2020-11-25 | 4 | Cavan John T | HEPA | Common Stock | D | 1.6200 | 4,500 | 7 | 4,800 | ||||
| 2020-08-21 | 2020-08-19 | 4 | BRANCACCIO JOHN P | HEPA | Stock Options | D | 3.72 | 30,000 | 91,332 | |||||
| 2020-08-21 | 2020-08-19 | 4 | ADAMS THOMAS PHD | HEPA | Stock Options | D | 3.72 | 30,000 | 91,050 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Block Timothy M. | HEPA | Stock Options | D | 3.72 | 30,000 | 91,276 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Lippa Arnold | HEPA | Stock Options | D | 3.72 | 30,000 | 91,110 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Foster Robert T | HEPA | Stock Options | D | 3.72 | 212,000 | 601,879 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Cavan John T | HEPA | Stock Options | D | 3.72 | 160,000 | 381,060 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Wijngaard Peter | HEPA | Stock Options | D | 3.72 | 30,000 | 60,000 | |||||
| 2020-08-21 | 2020-08-19 | 4 | JACOB GARY S | HEPA | Stock Options | D | 3.72 | 30,000 | 92,785 | |||||
| 2020-06-25 | 2020-06-25 | 4 | Wijngaard Peter | HEPA | Stock Options | D | 2.73 | 30,000 | 30,000 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Cavan John T | HEPA | Stock Options | D | 1.63 | 215,000 | 221,059 | |||||
| 2020-04-07 | 2020-04-03 | 4 | JACOB GARY S | HEPA | Stock Options | D | 1.63 | 60,000 | 62,729 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Foster Robert T | HEPA | Stock Options | D | 1.63 | 380,000 | 389,879 | |||||
| 2020-04-07 | 2020-04-03 | 4 | BRANCACCIO JOHN P | HEPA | Stock Options | D | 1.63 | 60,000 | 61,275 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Lippa Arnold | HEPA | Stock Options | D | 1.63 | 60,000 | 61,109 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Block Timothy M. | HEPA | Stock Options | D | 1.63 | 60,000 | 61,220 | |||||
| 2020-04-07 | 2020-04-03 | 4 | ADAMS THOMAS PHD | HEPA | Stock Option | D | 1.63 | 60,000 | 61,051 | |||||
| 2019-07-25 | 2019-07-24 | 4 | Lippa Arnold | HEPA | Stock Options | D | 3.24 | 970 | 1,109 | |||||
| 2019-07-25 | 2019-07-24 | 4 | Foster Robert T | HEPA | Stock Options | D | 3.24 | 9,700 | 9,879 | |||||
| 2019-07-25 | 2019-07-24 | 4 | ADAMS THOMAS PHD | HEPA | Stock Options | D | 3.24 | 970 | 1,051 | |||||
| 2019-07-25 | 2019-07-24 | 4 | Block Timothy M. | HEPA | Stock Options | D | 3.24 | 970 | 1,220 | |||||
| 2019-07-25 | 2019-07-24 | 4 | BRANCACCIO JOHN P | HEPA | Stock Options | D | 3.24 | 970 | 1,275 | |||||
| 2019-07-25 | 2019-07-24 | 4 | JACOB GARY S | HEPA | Stock Options | D | 3.24 | 970 | 2,729 | |||||
| 2019-07-25 | 2019-07-24 | 4 | Cavan John T | HEPA | Stock Options | D | 3.24 | 5,820 | 6,059 | |||||
| 2019-04-02 | 3 | Garlikov Donald E | CTRV | Common Stock | D | 6,640,000 | ||||||||
| 2019-04-02 | 3 | Garlikov Donald E | CTRV | Common Stock | D | 6,640,000 | ||||||||
| 2019-04-02 | 3 | Garlikov Donald E | CTRV | Common Stock | D | 6,640,000 | ||||||||
| 2018-07-03 | 2018-07-03 | 4 | BRANCACCIO JOHN P | CTRV | Warrants | D | 1.55 | 1,000.0000 | 1,725 | 1,725 | 1,725 | |||
| 2018-07-03 | 2018-07-03 | 4 | BRANCACCIO JOHN P | CTRV | Series C Convertible Preferred Stock | D | 1.55 | 1,000.0000 | 3 | 3 | 3 | |||
| 2018-07-03 | 2018-07-03 | 4 | Lippa Arnold Linda Lippa Family Trust of 2007 | CTRV | Warrants | I | 1.55 | 1,000.0000 | 8,625 | 8,625 | 8,625 | |||
| 2018-07-03 | 2018-07-03 | 4 | Lippa Arnold Linda Lippa Family Trust of 2007 | CTRV | Series C Convertible Preferred Stock | I | 1.55 | 1,000.0000 | 15 | 15 | 15 | |||
| 2018-07-03 | 2018-07-03 | 4 | Cavan John T | CTRV | Warrants | D | 1.55 | 1,000.0000 | 8,625 | 8,625 | 8,625 | |||
| 2018-07-03 | 2018-07-03 | 4 | Cavan John T | CTRV | Series C Convertible Preferred Stock | D | 1.55 | 1,000.0000 | 15 | 15 | 15 | |||
| 2018-07-03 | 2018-07-03 | 4 | JACOB GARY S | CTRV | Warrants | D | 1.55 | 1,000.0000 | 8,625 | 8,625 | 8,625 | |||
| 2018-07-03 | 2018-07-03 | 4 | JACOB GARY S | CTRV | Series C Convertible Preferred Stock | D | 1.55 | 1,000.0000 | 15 | 15 | 15 | |||
| 2018-01-05 | 2018-01-03 | 4 | Foster Robert T | CTRV | Common Stock | D | 100,654 | 144,736 | ||||||
| 2018-01-05 | 2018-01-03 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 322,092 | 492,819 | ||||||
| 2018-01-05 | 2018-01-03 | 4 | Cavan John T | CTRV | Common Stock | D | 101,221 | 167,947 | ||||||
| 2017-07-21 | 2017-07-20 | 4 | Cavan John T | CTRV | Stock Options | D | 0.58 | 15,000 | 133,688 | |||||
| 2017-07-07 | 2017-07-06 | 4 | Cavan John T | CTRV | Common Stock | D | 46,726 | 66,726 | ||||||
| 2017-07-07 | 2017-07-06 | 4 | Foster Robert T | CTRV | Common Stock | D | 44,082 | 44,082 | ||||||
| 2017-07-07 | 2017-07-06 | 4 | Sullivan-Bolyai John Z | CTRV | Common Stock | D | 58,681 | 58,681 | ||||||
| 2017-07-07 | 2017-07-06 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 141,061 | 170,727 | ||||||
| 2017-06-22 | 2017-06-20 | 4 | Cavan John T | CTRV | Common Stock | D | 0.6500 | 20,000 | 13 | 20,000 | ||||
| 2017-04-11 | 2017-04-10 | 4 | HOWSON TAMAR D | CTRV | Stock Options | D | 1.60 | 35,000 | 80,000 | |||||
| 2017-03-07 | 2017-03-06 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 1.48 | 313,898 | 2,761,129 | |||||
| 2017-03-07 | 2017-03-03 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 1.43 | 313,898 | 2,447,231 | |||||
| 2016-10-31 | 2016-10-27 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 1.50 | -16,666 | 2,133,334 | |||||
| 2016-10-31 | 2016-10-27 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 1.5000 | 16,666 | 25 | 29,666 | ||||
| 2016-08-29 | 2016-08-26 | 4 | Cavan John T | CTRV | Stock Options | D | 1.10 | 18,688 | 118,688 | |||||
| 2016-08-29 | 2016-08-26 | 4 | Sullivan-Bolyai John Z | CTRV | Stock Options | D | 1.10 | 135,790 | 290,790 | |||||
| 2016-08-17 | 3 | CERRONE GABRIEL By Panetta Partners Ltd. | CTRV | Common Stock | I | 10,289,012 | ||||||||
| 2016-08-17 | 3 | CERRONE GABRIEL | CTRV | Common Stock | D | 5,261,725 | ||||||||
| 2016-08-17 | 3 | CERRONE GABRIEL By Panetta Partners Ltd. | CTRV | Common Stock | I | 10,289,012 | ||||||||
| 2016-08-17 | 3 | CERRONE GABRIEL | CTRV | Common Stock | D | 5,261,725 | ||||||||
| 2016-07-20 | 2016-07-19 | 4 | JACOB GARY S | CTRV | Stock Options | D | 1.04 | 65,000 | 1,015,000 | |||||
| 2016-07-20 | 2016-07-19 | 4 | BRANCACCIO JOHN P | CTRV | Stock Options | D | 1.04 | 65,000 | 200,656 | |||||
| 2016-07-20 | 2016-07-19 | 4 | Lippa Arnold | CTRV | Stock Options | D | 1.04 | 32,500 | 77,500 | |||||
| 2016-07-20 | 2016-07-19 | 4 | Block Timothy M. | CTRV | Stock Options | D | 1.04 | 65,000 | 169,688 | |||||
| 2016-06-14 | 2016-06-13 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 0.99 | 500,000 | 2,150,000 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Sullivan-Bolyai John Z | CTRV | Stock Options | D | 0.99 | 20,000 | 155,000 | |||||
| 2016-03-02 | 3 | Sullivan-Bolyai John Z | CTRV | Common Stock | D | 42,000 | ||||||||
| 2016-03-02 | 3 | Sullivan-Bolyai John Z | CTRV | Common Stock | D | 42,000 | ||||||||
| 2016-02-18 | 2016-02-18 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 1.0000 | 10,000 | 10 | 13,000 | ||||
| 2015-12-01 | 2015-11-30 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 2.1500 | 500 | 1 | 3,000 | ||||
| 2015-11-24 | 2015-11-23 | 4 | SAPIRSTEIN JAMES | CTRV | Common Stock | D | 1.6400 | 2,500 | 4 | 2,500 | ||||
| 2015-06-08 | 2015-06-04 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 3.60 | 150,000 | 1,650,000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | Hornung William Karl | CTRV | Stock Options | D | 3.60 | 15,000 | 165,000 | |||||
| 2014-12-04 | 2014-12-03 | 4 | Block Timothy M. | CTRV | Stock Options | D | 1.50 | 29,911 | 104,688 | |||||
| 2014-12-04 | 2014-12-03 | 4 | Hornung William Karl | CTRV | Stock Options | D | 1.50 | 50,000 | 150,000 | |||||
| 2014-12-04 | 2014-12-03 | 4 | SAPIRSTEIN JAMES | CTRV | Stock Options | D | 1.50 | 500,000 | 1,500,000 | |||||
| 2014-12-04 | 2014-12-03 | 4 | McGuigan Christopher | CTRV | Stock Options | D | 1.50 | 118,638 | 415,234 | |||||
| 2014-12-04 | 2014-12-03 | 4 | BRANCACCIO JOHN P | CTRV | Stock Options | D | 1.50 | 38,759 | 135,656 | |||||
| 2014-12-04 | 2014-12-03 | 4 | JACOB GARY S | CTRV | Stock Options | D | 1.50 | 420,000 | 950,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Denoyer Bernard | CTRV | Stock Options | D | 2.35 | 20,000 | 40,000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | BRANCACCIO JOHN P | CTRV | Stock Options | D | 2.35 | 15,000 | 96,897 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Block Timothy M. | CTRV | Stock Options | D | 2.35 | 15,000 | 74,777 | |||||
| 2014-03-20 | 2014-03-19 | 4 | JACOB GARY S | CTRV | Stock Options | D | 2.31 | 300,000 | 530,000 | |||||
| 2014-03-14 | 2014-03-12 | 4 | BRANCACCIO JOHN P | CTRV | Stock Options | D | 2.37 | 21,897 | 81,897 | |||||
| 2014-03-14 | 2014-03-12 | 4 | McGuigan Christopher | CTRV | Stock Options | D | 2.37 | 16,596 | 296,596 | |||||
| 2014-03-14 | 2014-03-12 | 4 | Block Timothy M. | CTRV | Stock Options | D | 2.37 | 19,777 | 59,777 | |||||
| 2014-03-07 | 2014-03-04 | 4 | BRANCACCIO JOHN P | CTRV | Common Stock, par value $0.0001 per share | D | 1.4900 | 4,393 | 7 | 6,408 | ||||
| 2014-02-20 | 2014-02-18 | 4 | SYNERGY PHARMACEUTICALS, INC. | CTRV | Common Stock, par value $0.0001 per share | D | -9,000,000 | 0 | ||||||
| 2014-02-20 | 2014-02-18 | 4 | BRANCACCIO JOHN P | CTRV | Common Stock, par value $0.0001 per share | D | 2,015 | 2,015 | ||||||
| 2014-02-20 | 2014-02-18 | 4 | JACOB GARY S | CTRV | Common Stock, par value $0.0001 per share | D | 32,935 | 32,935 | ||||||
| 2014-02-20 | 2014-02-18 | 4 | Denoyer Bernard | CTRV | Common Stock, par value $0.0001 per share | D | 1,030 | 1,030 | ||||||
| 2014-01-28 | 2014-01-24 | 4 | McGuigan Christopher | NONE | Stock Options | D | 0.37 | 250,000 | 280,000 | |||||
| 2014-01-28 | 2014-01-24 | 4 | JACOB GARY S | NONE | Stock Options | D | 0.37 | 200,000 | 230,000 | |||||
| 2014-01-28 | 2014-01-24 | 4 | Denoyer Bernard | NONE | Stock Options | D | 0.37 | 10,000 | 20,000 | |||||
| 2014-01-28 | 2014-01-24 | 4 | BRANCACCIO JOHN P | NONE | Stock Options | D | 0.37 | 30,000 | 60,000 | |||||
| 2014-01-28 | 2014-01-24 | 4 | Block Timothy M. | NONE | Stock Options | D | 0.37 | 10,000 | 40,000 | |||||
| 2013-11-26 | 2013-11-26 | 4 | Denoyer Bernard | NONE | Stock Options | D | 0.11 | 10,000 | 10,000 | |||||
| 2013-10-07 | 3 | SYNERGY PHARMACEUTICALS, INC. | NONE | Common Stock, par value $0.0001 per share | D | 9,000,000 |
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）
